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Abstract 
Introduction        
       Sickle cell disease is inherited as an autosomal recessive manner. HbS differs from HbA in the 
substitution of valine for glutamic acid in the sixth position of the -globin chain. Heterozygous state for 
the HbS gene. Comprises 25-45% of the total hemoglobin, the rest being Hb-A, Hb-A2 and Hb-F. 
.      
Zinc status in children with sickle cell disease was determined in 1975, the finding, showed that 
there was  a significant decrease in zinc level in plasma, erythrocyte and hair. However, urinary zinc 
excretion was increased in sickle cell disease patients and is associated with decreased linear growth, 
skeletal growth, and muscle mass and sexual and skeletal maturation.  . Information regarding zinc status 
in sickle cell disease in Sudanese subjects is needed.  
        The objective of this study was to determine the zinc status in patients with sickle cell disease in 
addition to other related parameters including Haemoglobin level, total white blood cells count, sickling 
test, and identification of malaria parasite in the blood in the patients and control group. Anthropometric 
measurements including body weight, body height, and body mass index were also conducted.  
Study Design: 
         This is a case control study designed to study zinc status in patients with Sickle Cell Disease 
attending Wad Medani Paediatric Teaching Hospital in Gezira State. 
        Forty four patients diagnosed as sickle cell disease by clinical features and laboratory investigations 
(Hb Electrophoresis) were enrolled in this study. Fifty normal subjects were taken as control group. Patients 
with malnutrition and other diseases were excluded. 
 
Results  
      In the present  study the mean of serum zinc concentration in the patients group(40.8 ±20 µg/dl) 
was significantly lower than  control group (55.3 ±32.4 µg/dl) (P < 0.05). Haemoglobin concentration in 
patients (6.6 ± 0.9 g/dl) was significantly lower (P< 0.001) compared to control group (11.1±2.1 g/dl).  The 
result of this study also showed that the values of  TWBCs count for the patients group (16150 ± 8196 cell 
/ µL) was significantly higher (P < 0.001) compared to control group (5750 ± 3537 cell / µL ). The mean 
body weight (16.3 ± 8.2 kg), body height (103 ± 26 cm), and BMIs (14.5 ± 1.9) in the patients were 
significantly lower compared to control group (23.7 ± 8.0 kg), (120 ± 17 cm), (16.1 ± 3.2) respectively  (P 
< 0.001). All patients showed negative blood film for malaria parasite with the exception of only one 
subject, while three subjects of control group showed positive blood film for malaria parasite 
Conclusion 
Zinc status in patients with sickle cell disease in central Sudan is significantly lower than that of 
control group. Patients had lower hemoglobin level, lower body weight and height, and higher total white 
blood cell count than control group. 
All patients showed negative blood film for malaria parasite with exception of only one subject, while three 
subjects of control group showed positive blood film for malaria parasite.  
Because of low zinc level in patients with sickle cell disease, zinc supplementation is recommended. 
Further studies are needed to see its effect on the different parameters 
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    Sickle cell disease including the homozygous and heterozygous states of sickle cell gene,  were  
reviewed by Greer and his colleagues,  who reported that long before they were known in western 
hemisphere, sickling disorders were known in Africa by local names denoting the recurrent, unrelenting, 
and painful nature of the crisis1. 
Internationally, the mutation that results in hemoglobin S is felt to have originated in several 
locations of Africa and India. Its prevalence is variable, but very high in these countries, due to the survival 
advantage to heterozygote in regions of endemic malaria. As a result of migration, both forced and 
voluntary, it is now found worldwide. Recent data indicate that 15% of children born with sickle cell anemia 
die by the age of 20 years. Median survival age is 42 years for men and 48 years for women, which is 25-
30 years lower than expected for the African American population. These data were generated prior to the 
institution of penicillin prophylaxis. Earlier diagnosis and improved supportive care are expected to 
substantially decrease mortality for children 2. 
Haemoglobin is a conjugated protein composed of four subunits two  and two -chains; each unit 
contains iron in the divalent ferrous, (Fe+2) state3. The genes for the globin chains occur in two clusters 4. 
The  gene complex is situated on the short arm of the chromosome 16 and includes the duplicated  genes 
(1 and 2), anon-functional pseudo  gene (41) and two  genes, one of which is probably non-functional. 
The non- gene complex is situated on the short arm of chromosome 11 and includes, and  genes the 
duplicated   genes (G and A), the  gene and non-functional pseudo  gene (41)5. 
        Hb transports O2 from respiratory organ to peripheral tissues. Acts as one of the buffers in blood, 
accounting for about 70% of its buffering power 3.  HbS differs from HbA in the substitution of valine for 
glutamic acid in the sixth position of the -globin chain5. 
        Hbs has poor solubility in deoxygenated state and can polymerize within the red cell leading to its 
characteristic shape, rigid membrane, generation of oxidant substances and abnormal adherence of the red 
cells to vascular endothelium6 Sickle cell is inherited as an autosomal recessive7.  
         Heterozygous state for the HbS gene, comprises 25-45% of the total haemoglobin, the rest being 
Hb-A, Hb-A2 and Hb-F.  
         Sickle cell trait does not cause anaemia and in general is asymptomatic5. In vivo sickling occurs 
only at very high altitude and low oxygen pressures. Hematuria is the most common symptom owing to 
sickling in the renal papillae and is found in about 1% of people with sickle cell trait 6.    
Homozygous Sickle cell anaemia (HbSS) is the most common type of the sickle cell disease4. 
The in vivo Sickling is responsible for the clinical manifestation of the disease, these are: chronic anaemia1, 
10, 11. Organ damage and episodes of pain1, 5,7,8,9.           
      Other variants of sickle cell, Hb-C disease, HbSE, and HSD Clinically they resemble homozygous 
sickle cell disease but are less severe and the patient are mildly anaemic. Most have a relatively normal life 
with only very occasional painful crisis. The electrophoretic pattern may be confused with that of 
homozygous sickle cell disease 
         Zinc is an essential trace element, it was found to be biologically important more than 100 years for 
the growth of certain bacteria. 
           In 1920s it was demonstrated to be required for the growth of experimental rats. But, it was not until 
early 1960s that zinc was shown to be an essential nutrient of man12. 
It is important in activating certain serum enzymes13, needed for DNA synthesis, synthesis and 
metabolism of proteins. Acts as growth factor. Required for cell division14, for development and functioning 
of reproductive system12. Supports a healthy immune system15. Needed for wound healing16, and for normal 
taste and smell17.  
Zinc status in children with sickle cell disease was determined in 1975, the finding, showed that 
there was a significant decrease in zinc level in plasma, erythrocyte and hair, and however, urinary zinc 
excretion was increased in anemia patients18. 
      In 1979 zinc status was studied in 47 children with homozygous sickle cell disease. Decreased hair 
and plasma zinc was demonstrated in these children and hyperzincuria was found in the older patients. This 
study indicates that zinc deficiency in patients with SCD is probably due to hyperzincuria19. 
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  Results of controlled trial with zinc supplementation for 14-19 years old sickle cell anemia subjects 
who were retarded in growth showed that zinc supplementation significantly improved longitudinal growth 
and body weight of these subjects20. 
  Zinc and Copper status in 57 patients with sickle cell anemia and in 45 control patients from eastern 
province of Saudi Arabia were studied. Plasma zinc and copper levels in patients were found to be close to 
those of the control subjects. Similarly, there was no difference neither in urinary zinc level nor in the ratio 
of Cu: Zn in patients and control subjects. This is in contrast to the situation which existed in North 
American black subjects with sickle cell anemia who were known to have zinc deficiency as well as a 
further decrease in zinc level during sickle cell crisis. The near normal level of zinc and copper found in 
Saudi sickle cell patients therefore exclude zinc deficiency and confirmed that this population exhibited a 
milder form of SCD21.   
     In 1988 zinc status was studied in 80 children with sickle cell disease (SCD) and 44 disease free 
siblings control aged 3-18 years. They found, zinc status in SCD was not related to inadequate dietary 
intake. The origin of low serum zinc levels in children with SCD is most likely related to increased urinary 
zinc excretion, chronic intravascular hemolysis22. 
    Copper, zinc and iron and their interrelations in SCD patients were studied, iron deficiency, 
hypercopperemia and low plasma zinc level foud are attributed to their short stature23.  
Leonard and his colleagues studied the relation of plasma zinc status to growth and maturation in 
children with sickle cell disease. The result showed that, decreased plasma zinc is common, and is 
associated with decreased linear growth, skeletal growth, and muscle mass and sexual and skeletal 
maturation 24.   
 Evaluation of zinc and anti-oxidant vitamins in patients with severe sickle cell anemia indicated 
that there was a significant decrease in plasma level of vitamin A, C, and E and in serum level of zinc on 
these patients. Serum copper levels were significantly elevated compared to control25. 
      Although it has been known for more than 6 decades that zinc is essential for growth of micro-
organisms, plants, and animals, it was believed that zinc deficiency in humans could never occur. It is now 
clear that nutritional deficiency of zinc is widely prevalent and its morbidities are severe.  
Zinc deficiency leads to growth retardation; hypogonadism in males, cell-mediated immune 
disorder, impaired wound healing and reduced insulin function. 
         Information regarding zinc status in sickle cell disease in Sudanese subjects is needed. 
Objective. 
The main objective is to determine Serum zinc concentration in patients with SCD, and to study 
other related parameters likeWBCs count, Haemoglobin level, Weight and Height, BMIs in patients and 
control groups 
 
SUBJECTS, MATERIALS, AND METHODS 
Study Design and subjects: 
         This is a case control study designed to study zinc status in patients with Sickle Cell Disease 
attending Wad Medani Paediatric Teaching Hospital in Gezira State. 
        Forty four patients diagnosed as sicklers by clinical features and laboratory investigations ( Hb 
Electrophoresis) were enrolled in this study. Fifty normal subjects were taken as control group. 
Exclusion criteria: Patients with malnutrition and other diseases were excluded from this study. 
       Verbal consent was taken from the care takers of the study groups. 
 Materials: 
 Blood Sample: 
         Five ml of venous blood were drawn from each patient using disposable sterile syringe and divided 
into two parts; the first part 2 ml, was transferred to polyethylene container coated with anticoagulant 
(EDTA) and were used for haematological test and identification of malaria parasite. The remaining 3 ml 
was centrifuged. Serum was kept in -20c, analyzed for zinc at the National Research Centre using atomic 
absorption spectrophotometer. 27 
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Microscope was used for sickling test26. And identifying of malaria parasite28. 
Hb electrophoresis was used to distinguish between different variants of haemoglobin26. Haemocytmeter 
was used for TWBCs count28. Colorimeter was used for the estimation of Hb26 
For each patient questionnaire was designed to get informations about age, sex and tribe. 
Anthropometric measurements of study subjects: 
All subjects were weighed on equilibrated portable balance scale30. 
Standing height was measured without shoes using a tape measure fixed to the wall30. Body Mass Index 
(BMI) was calculated). 
Statistical Analysis: 
         Different variables were presented as mean  standard deviation. Analysis of variance (ONE WAY 
ANOVA) was applied for comparison between different groups. The confidence limit was 95%, the P value 
was considered significant at a value less than 0.05. 
Statistical analysis was done using SPSS program (ver. 9) under windows (XP) computer system. 
 
Results 
          Forty four patients diagnosed as sickle cell disease (SCD) recruited from Wad Medani Paediatric 
Teaching Hospital, were selected in this study. Patients with negative sickling test and normal 
electrophoretic pattern of haemoglobin were excluded from this study. 
The minimum age of study subjects was one year old, the maximum 17 years old and the mean was 
6.0 ± 4.6. years. The highest incidence of disease was shown between the ages from 1 – 5 years (Table 1,). 
28 (63.6%) were male and 16 (36.4%) were female. Of all patients only one patient had positive film for 
malaria parasite. 
 
Table 1 Age and Sex in SCD patients 
Sex Male Female Total 
Age group No % No % No % 
1 – 5 years 20 71.4 4 25 24 54.5 
6 – 10 years 6 21.4 6 37.5 12 27.3 
11 – 17years 2 7.1 6 37.5 8 18.2 
Total 28 100 16 100 44 100 
 
The studied subjects extended along 14 different tribes, about 58.5% of them belonged to three 
tribes, (26.8%) Hawsa, (17.1%)  Bargo, and (14.6%) Selehab (Figure 1) 
 
Figure (1):  Distribution of the respondents according to their tribes 
Zinc and Hb were found to be lower in patients compared with control group, while TWBCs counts were 
higher in patients than control (table2) 
Table -2: Biochemical parameters in patients and control groups (Mean ± SD) 
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Parameter Patients Control 
No Mean ± SD No Mean ± SD 
Zinc µg/dl 44 40.8 ± 20. 50 55.3 ± 32.4* 
Hb g/dl 42 6.6 ± 0.9 50 11.1 ± 2.1*** 
TWBCs(Cell/µl) 42 16150 ± 8196 50 5750 ± 3537.9*** 
No: number of subjects 
*: significant at P < 0.05 
***: significant at P < 0.001 
Anthropometric measurements showed highly significant differences in the mean between the two 
groups. 
Table -3: Anthropometric measurements in patients and control groups (Mean ± SD) 
Parameter Patients Control Significance 
No Mean ± SD No Mean ± SD 
Weight(Kg) 40 16 ± 8 47 24 ± 8 S*** 
Height(cm) 40 103 ± 26 50 120 ± 17 S*** 
BMIs 40 15 ± 2 47 16 ± 3 S** 
No: number of subjects 
S**: significant at P < 0.01 
S***: significant at P < 0.001 
 
Discussion 
In this study all patients were homozygous sickle cell anaemia patients. They belongs to Afro –Arab 
,Afro-Asiatic ,and African tribes 34,35Due to excessive haemolysis of sickled red blood cells ,all patients in 
study group are having significantly low heamoglobin as compared  with  the control .This results agrees 
with other studies in sudan35,36,37  
           Zinc deficiency has been known of 40 years but ignored by global health organization 22 .In patient 
with sickle cell disease zinc deficiency is well known from different studies18,19,20.In Sudan there is no study 
looked at the level of zinc in patient with sickle cell disease. In the present study the mean serum zinc 
concentration in the patients group (40.8 ±20 µg/dl) were significantly lower (P < 0.05) compared to control 
group (55.3 ±32.4 µg/dl) and reported normal values. This is also in agreement with Phebus et al22 finding 
in Pittsburgh who reported that serum zinc concentration of 77.8µg/dl of sickle cell disease patients versus 
(82.2 ± 9.8µg/dl). Our results also agree with those of Prasad 18 and Leonard et al24 who attributed this low 
levels to increased urine excretion of zinc in sickler patient. Our result disagree with Alayash et al 21  from 
the eastern province of Saudi Arabia who  found that plasma zinc level in patients were found to be close 
to those of control subjects, and attributed this to mild form of sickle cell anaemia exhibited by the patients.  
The result of this study showed that the values of TWBCs for the patients group was significantly 
higher as compared to control group (P < 0.001).which agrees with studies done in Sudan36, 38 which showed 
increased incidence of bacterial infections as compared with normal children. The same study showed 
partial protection against malaria in children with sickle cell disease, it agrees with our finding as we 
observed that only one patient has a positive blood film for malaria.. 
The mean body weight and height in the patients were significantly lower as compared to control 
group (P < 0.001), and standard reference value for BMI32. This is in agreement with study in Sudan and 
others33, 38 which can be explained in the context of zinc deficiency. 
 
Conclusions 
It can be concluded from this study that: 
 Zinc status in patients with sickle cell disease in central Sudan is significantly lower than that of control 
group. 
 Patients had lower haemoglobin level, lower body weight and height, and higher total white blood cell 
count than control group. 
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 All patients showed negative blood film for malaria parasite with exception of only one subject, while 
three subjects of control group showed positive blood film for malaria parasite. 
 
 
Recomendations 
Because of poor zinc status in patients with sickle cell disease, zinc supplementation is 
recommended. Further studies are needed to see its effect on the different parameters. 
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